To our knowledge, we are the first to report plasma levels of fractalkine, GRO-α, IL-12/IL-23p40, IL-18, IL-2Rα, TGF-β1, TGF-β2, TGF-β3, TRAIL, and VEFG-A in individuals with ADHD. The gene discussed is TGFB2; the disease is attention deficit-hyperactivity disorder.